Mildly oxidized low-density lipoprotein inhibits the in vitro induction of the specific antibody response to Candida albicans

Free Radical Biology and Medicine

Volumn 39, Issue 7, 2005, Pages 960-969

  Giordani, Luciana ^a   Mattioli, Benedetta ^a   Quaranta, Maria Giovanna ^a   Giacomini, Elena ^a   Libri, Irene ^a   Varì, Rosaria ^a   Masella, Roberta ^a   Viora, Marina ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Antigen specific antibody response; Free radicals; Human B cells; IgM anti mLDL; IL 1 ; Oxidized LDL; Polyclonal immunoglobulin production

Indexed keywords

IMMUNOGLOBULIN M; INTERLEUKIN 1BETA; LOW DENSITY LIPOPROTEIN; RECOMBINANT INTERLEUKIN 1; RECOMBINANT PROTEIN;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CANDIDA ALBICANS; CELL FUNCTION; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOGLOBULIN PRODUCTION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; NORMAL HUMAN; OXIDATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING;

CANDIDA ALBICANS;

EID: 33644620371     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.05.012     Document Type: Article

References (65)

1. Ylä-Herttuala, S.; Rosenfeld, M. E.; Parthasarathy, S.; Carew, T. E.; Butler, S.; Witztum, J. L.; Steinberg, D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1086-1095; 1989.
2. Witztum, J. L.; Steinberg, D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1785-1792; 1991.
3. Frostegard, J.; Nilsson, J.; Haegerstrand, A.; Hamsten, A.; Wigzell, H.; Gidlund, M. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc. Natl. Acad. Sci. USA 87:904-908; 1990.
4. Rajavashisth, T.; Yamada, H.; Mishra, N. K. Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL. Arterioscler. Thromb. Vasc. Biol. 15:1591-1598; 1995.
5. Cushing, S. D.; Berliner, J. A.; Valente, A. J.; Territo, M. C.; Mahamad, N.; Parhami, F.; Gerrity, R.; Schwartz, C. J.; Fogelman, A. M. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth cells. Proc. Natl. Acad. Sci. USA 87:5134-5138; 1990.
6. McMurray, H. F.; Parthasarathy, S.; Steinberg, D. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J. Clin. Invest. 92:1004-1008; 1993.
7. Augé, N.; Pieraggi, M. T.; Thiers, J. C.; Nègre-Salvayre, A.; Salvayre, R. Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochem. J. 309:1015-1020; 1995.
8. Tuzcu, E. M.; Kapadia, S. R.; Tutar, E.; Ziada, K. M.; Hobbs, R. E.; McCarthy, P. M.; Young, J. B.; Nissen, S. E. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 103:2705-2710; 2001.
9. Erkkila, A. T.; Narvanen, O.; Lehto, S. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 20:204-209; 2000.
10. Shaw, P. X.; Horkkö, S.; Chang, M. K.; Curtiss, L. K.; Palinski, W.; Silverman, G. J.; Witztum, J. L. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105:1731-1740; 2000.
11. Yla-Herttuala, S.; Palinski, W.; Butler, S. W.; Picard, S.; Steinberg, D.; Witztum, J. L. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14:32-34; 1994.
12. Hörkkö, S.; Binder, C. J.; Shaw, P. X.; Chang, M. K.; Silverman, G. J.; Palinski, W; Witztum, J. L. Immunological responses to oxidized LDL. Free Radic. Biol. Med. 28:1771-1779; 2000.
13. Palinski, W; Witztum, J. L. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. J. Intern. Med. 247:371-380; 2000.
14. Shaw, P. X.; Horkko, S.; Tsimikas, S.; Chang, M. K.; Silverman, G. J.; Palinski, W.; Chen, P. P.; Witztum, J. L. Human-derived antioxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo. Arterioscler. Thromb. Vasc. Biol 21:1333-1339; 2001.
15. Binder, C. J.; Chang, M. K.; Shaw, P. X.; Miller, Y I.; Hartvigsen, K.; Dewan, A.; Witztum, J. L. Innate and acquired immunity in atherogenesis. Nat. Med. 8:1218-1226; 2002.
16. Morel, D. W; Hessier, J. R.; Chisolm, G. M. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J. Lipid Res. 24:1070-1076; 1983.
17. Cathcart, M. K.; Morel, D. W; Chisolm, G. M. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J. Leukocyte Biol. 38:341-350; 1985.
18. Henriksen, T.; Mahoney, E. M.; Steinberg, D. Enhanced macrophage degradation of low density lipoprotein previously incubated with endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc. Natl. Acad. Sci. USA 81:3883-3887; 1981.
19. + cells: effect of interleukin 2. Cell. Immunol. 167:18-29; 1996.
20. Malorni, W.; Straface, E.; Di Geneva, G.; Fattorossi, A.; Rivabene, R.; Camponeschi, B.; Masella, R.; Viora, M. Oxidized low-density lipoproteins affect natural killer cell activity by impairing cytoskeleton function and altering the cytokine network. Exp. Cell Res. 236:436-445; 1997.
21. Viora, M.; Quaranta, M. G.; Straface, E.; Varì, R.; Masella, R.; Malorni, W. Redox imbalance and immune functions: opposite effects of oxidized low-density lipoproteins and N-acetylcysteine. Immunology 104:431-438; 2001.
22. Viora, M.; Straface, E.; Di Geneva, G.; Fattorossi, A.; Rivabene, R.; Camponeschi, B.; Masella, R.; Malorni, W. Oxidized low density lipoproteins impair peripheral blood mononuclear cell proliferation and cytokine production. Biochem. Biophys. Res. Commun. 232:359-363; 1997.
23. Viau, M.; Zouali, M. B-lymphocytes, innate immunity, and autoimmunity. Clin. Immunol. 114:17-26; 2005.
24. Hansson, G. K. Regulation of immune mechanisms in atherosclerosis. Ann. N.Y. Acad. Sci. 947:157-165; 2001.
25. Hansson, G. K.; Jonasson, L.; Seifert, P. S.; Stemme, S. Immune mechanisms in atherosclerosis. Arteriosclerosis 9:567-578; 1989.
26. Alcouffe, J.; Therville, N.; Ségui, B.; Nazzal, D.; Blaes, N.; Salvayre, R.; Thomsen, M.; Benoist, H. Expression of membrane-bound and soluble FasL in Fas- and FADD-dependent T lymphocyte apoptosis induced by mildly oxidized LDL. FASEB J. 18:122-124; 2004.
27. Asmis, R.; Begley, J. G. Oxidized LDL promotes peroxide-mediated mitochondrial dysfunction and cell death in human macrophages: a caspase-3-independent pathway. Circ. Res. 92:20-29; 2003.
28. Fortun, A.; Khalil, A.; Gagne, D.; Douziech, N.; Kuntz, C.; Jay-Gerin, J. P.; Dupuis, G.; Fulop, T., Jr. Monocytes influence the fate of T cells challenged with oxidised low density lipoproteins towards apoptosis or MHC-restricted proliferation. Atherosclerosis 156:11-21; 2001.
29. Perrin-Cocon, L.; Coutant, F.; Agaugue, S.; Deforges, S.; Andre, P.; Lotteau, V Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte. J. Immunol. 167:3785-3791; 2001.
30. Den Coutant, F.; Agaugue, S.; Perrin-Cocon, L.; Andre, P.; Lotteau, V Sensing environmental lipids by dendritic cell modulates its function. J. Immunol. 172:54-60; 2004.
31. Torosantucci, A.; Palma, C.; Boccanera, M.; Ausiello, C. M.; Spagnoli, G. C.; Cassone, A. Lymphoproliferative and cytotoxic responses in cultures of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans, J. Gen. Microbiol. 136:2155-2163; 1990.
32. Cassone, A.; De Bernardis, F.; Ausiello, C. M.; Gomez, M. J.; Boccanera, M.; Valle, R.; La, A. Immunogenetic and protective Candida albicans constituents. Res. Immunol. 149:289-299; 1998.
33. Chung, B. H.; Segrest, J. P.; Ray, M. J. Single vertical spin density ultracentrifugation. Methods Enzymol. 128:181-209; 1986.
34. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of dye-binding. Anal. Biochem. 72:248-254; 1976.
35. El-Saadani, M.; Esterbauer, H.; El-Sayed, M.; Goher, M.; Nassar, A. Y.; Yurgens, G. A. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res. 30:627-630; 1989.
36. Niehaus, W. G.; Samuelsson, B. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur. J. Biochem. 17:126-130; 1968.
37. Masella, R.; Varì, R.; D'Archivio, M.; Di Benedetto, R.; Matarrese, P.; Malorni, W.; Scazzocchio, B.; Giovannini, C. Extra virgin olive oil biophenols inhibit cell-mediated oxidation of LDL by increasing the mRNA transcription of glutathione-related enzymes. J. Nutr. 134:785-791; 2004.
38. Luzzati, A. L. Induction of an antibody response in cultures of human peripheral blood lymphocytes. In: Lefkovits, I.; Pernis, B., eds. Immunological Methods. London: Academic Press; 1981:241-246.
39. Giacomini, E.; Boccanera, M.; Giordani, L.; Cassone, A.; Luzzati, A. L. Induction of antibody forming cells with specificity for Candida albicans mannoproteins in cultures of human peripheral blood lymph ocytes. J. Immunol. Methods 164:203-211; 1993.
40. Sedgwick, J. D.; Holt, P. G. ELISA-plaque assay for the detection of single antibody-secreting cells. In: Kemeny, D. M.; Challacombe, S. J., eds. ELISA and Other Solid Phase Immunoassays. Chichester: Wiley; 1988:241-263.
41. Barbieri, D.; Grassilli, E.; Monti, D. D-Ribose and deoxy-D-ribose induce apoptosis in human quiescent peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 201:1109-1116; 1994.
42. Versteegen, J. M.; Logtenberg, T.; Ballieux, R. E. Enumeration of IFN-gamma-producing human lymphocytes by spot-ELISA: a method to detect lymphokine-producing lymphocytes at the single-cell level. J. Immunol. Methods 111:25-29; 1988.
43. Haraguchi, S.; Good, R. A.; James-Yarish, M.; Cianciolo, G. J. Differential modulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. Proc. Natl. Acad. Sci. USA 92:3611-3615; 1995.
44. Giordani, L.; Giacomini, E.; Quaranta, M. G.; Viora, M. HIV-Nef protein inhibits the in vitro induction of a specific antibody response to Candida albicans by an early up-regulation of IL-15 production. Clin. Exp. Immunol. 122:358-363; 2000.
45. Krieger, M.; Herz, J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63:601-637; 1994.
46. Falcone, D. J.; Ferenc, M. J. Acetyl-LDL stimulates macrophage-dependent plasminogen activation and degradation of extracellular matrix. J. Cell. Physiol. 135:387-396; 1988.
47. Falcone, D. J.; McCaffrey, T. A.; Vergilio, J. A. Stimulation of macrophage urokinase expression by polyanions is protein kinase C-dependent and requires protein and RNA synthesis. J. Biol. Chem. 226:22726-22732; 1991.
48. Steinbrecher, U. P. Receptors for oxidized low density lipoprotein. Biochim. Biophys. Acta 1436:279-298; 1999.
49. Dhaliwal, B. S.; Steinbrecher, U. P. Scavenger receptors and oxidized low density lipoproteins. Clin. Chim. Acta 286:191-205; 1999.
50. Calvo, D.; Gòmez-Coronado, D.; Lasunciòn, M. A.; Vega, M. A. CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high affinity receptor for both native (HDL, LDL and VLDL) and modified (ox-LDL and acLDL) lipoprotein. Arterioscler. Thromb. Vasc. Biol 7:234-239; 1997.
51. Calvo, D.; Gòmez-Coronado, D.; Suàrez, Y.; Lasunciòn, M. A. Human CD36 is a high affinity receptor for the native lipoproteins HDLm, HDL, and VLDL. J. Lipid Res. 39:777-788; 1998.
52. El Khoury, J.; Hickman Thomas, C. A.; Cao, L.; Silverstein, S. C.; Loike, J. D. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature 382:716-719; 1996.
53. Boullier, A.; Gillotte, K. L.; Horkko, S.; Green, S. R.; Friedman, P.; Dennis, E. A.; Witztum, J. L.; Steinberg, D.; Quehenberger, O. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J. Biol. Chem. 275:9163-9169; 2000.
54. Greaves, D. R.; Channon, K. M. Inflammation and immune responses in atherosclerosis. Trends Immunol. 23:535-541; 2002.
55. Dinarello, C. A. Biologic basis for interleukin-1 in disease. Blood 87:2095-2147; 1996.
56. Tocci, M. J.; Schmidt, J. A. Interleukin-1: structure and function. In: Remick, D. G.; Friedland, J. S., eds. Cytokines in health and disease. New York: Dekker; 1997:1-27.
57. Dinarello, C. A. Interleukin-1. Cytokine Growth Factor Rev. 8:253-265; 1997.
58. Dinarello, C. A. Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652; 1991.
59. Nakae, S.; Asano, M.; Horai, R.; Iwakura, Y. Interleukin-1 beta, but not interleukin-1 alpha, is required for T-cell-dependent antibody production. Immunology 104:402-409; 2001.
60. Giacomini, E.; Giordani, L.; Di Modugno, F.; Chersi, A.; Luzzati, A. L. Increased PGE2 production mediates the in vitro inhibitory effect of the human immunodeficiency virus P24 immunosuppressive heptapeptide Ch7. Scand. J. Immunol. 48:248-253; 1998.
61. Vos, Q.; Lees, A.; Wu, Z. Q.; Snapper, C. M.; Mond, J. J. B-cell activation by T cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol. Rev. 176:154-170; 2000.
62. Binder, C. J.; Hartvigsen, K.; Chang, M. K.; Miller, M.; Broide, D.; Palinski, W.; Curtiss, L. K.; Corr, M.; Witztum, J. L. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J. Clin. Invest. 114:427-437; 2004.
63. Harnett, W.; Harnett, M. M. Phosphorylcholine: friend or foe of the immune system? Immunol. Today 20:125-129; 1999.
64. Palinski, W.; Horkko, S.; Miller, E.; Steinbrecher, U. P.; Powell, H. C.; Curtiss, L. K.; Witztum, J. L. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice: demonstration of epitopes of oxidized low density lipoprotein in human plasma. J. Clin. Invest. 98:800-814; 1996.
65. Corcoran, L.; Vremec, D.; Febbraio, M.; Baldwin, T.; Handman, E. Differential regulation of CD36 expression in antigen-presenting cells: Oct-2 dependence in B lymphocytes but not dendritic cells or macrophages. Int. Immunol. 14:1099-1104; 2002.